AbCellera Biologics Inc.ABCLNASDAQ
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank29
3Y CAGR+36.2%
5Y CAGR-21.0%
Year-over-Year Change
Enterprise value to sales ratio
3Y CAGR
+36.2%/yr
vs -73.0%/yr prior
5Y CAGR
-21.0%/yr
Recent acceleration
Acceleration
+109.2pp
Accelerating
Percentile
P29
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
2 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 13.44 | -49.8% |
| 2024 | 26.75 | -36.2% |
| 2023 | 41.95 | +688.3% |
| 2022 | 5.32 | -43.1% |
| 2021 | 9.35 | -78.6% |
| 2020 | 43.70 | -96.0% |
| 2019 | 1092.60 | +8.5% |
| 2018 | 1006.76 | - |